PaO – Page 17 – Communicable Diseases Research

Tracheal Tube Obstruction Due to Hemoptysis Associated With Pulmonary Infarction in a Patient With Severe COVID-19 Pneumonia

Emergency Medicine

Published on 2021-02-272022-10-31
Journal: Cureus [Category] COVID-19,

Vitamin D and Lung Outcomes in Elderly COVID-19 Patients

노인 COVID-19 환자의 비타민 D 및 폐 결과

Clinical Trial

Published on 2021-02-242022-08-13
Journal: Nutrients [Category] MERS, 임상, 진단,

[키워드] 25OH-vitamin D 25OH-vitamin D serum age age-matched control analyzed C-reactive protein C-reactive protein) clinical parameter Clinical parameters CNT collected Comorbidities Comorbidity Computed tomography Concentration COVID-19 COVID-19 patient COVID-19 patients D-dimer deficiency died disease disease severity elderly Elderly patient elderly patients evaluated Hospitalization Hospitalized Infection interstitial lung involvement laboratory parameter Laboratory parameters less lung involvement median Mild multiple lung consolidation multiple lung consolidations negative correlation PaO parameters patients with SARS-CoV-2 positive correlation pulmonary involvement radiologic reported respiratory respiratory parameter respiratory parameters risk factor risk of death SARS-CoV-2 SARS-COV-2 infection serum severity Sex significantly lower statistically significant subject those who survived venturi mask Vitamin D vitamin D deficiency vitamin D level vitamin D serum
[DOI] 10.3390/nu13030717 PMC 바로가기 [Article Type] Clinical Trial

Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak

Observational Study

Published on 2021-02-242022-10-04
Journal: Critical Care [Category] MERS, 임상,

[키워드] advanced respiratory support age benefit breath C-reactive protein Care collected data Coronavirus pneumonia COVID-19 COVID-19 outbreak CPAP death defined DNI effective feasible Gas exchange health care systems Helmet continuous positive airways pressure CPAP high mortality hypoxic ICU impairment IMPROVE intensive care intubation limitation majority non-rebreathing mask Noninvasive ventilation number of comorbidity outcome oxygen pandemic PaO Patient patients died Pneumonia positive airway pressure Positive end expiratory pressure PEEP Registration required respiratory respiratory rate Result standard oxygen therapy survival therapy treat treated Treatment was used were recorded
[DOI] 10.1186/s13054-021-03502-y PMC 바로가기 [Article Type] Observational Study

Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection

SARS-CoV-2 감염 입원 환자의 토실리주맙 실패 예측 모델 개발 및 검증

Research Article

Published on 2021-02-232022-09-12
Journal: PLoS ONE [Category] 진단,

[키워드] Accuracy Analysis assist AUC clinician Cohort composite endpoint Course CRP death develop development died Factor Follow-up generate hospital hospitalized patient identify identifying inclusion criteria independent logistic regression model mechanical ventilation Mortality multicenter cohort study multivariable analysis multivariable logistic regression models outcome PaO Patient patients treated Platelet Platelets post treatment predictor receiving Result retrospective risk SARS-COV-2 infection secondary secondary outcome selected severe pneumonia Sex Standard of care study outcome study outcomes TESEO Therapies Tocilizumab tocilizumab administration treatment initiation treatment with tocilizumab validation cohort were used with COVID-19
[DOI] 10.1371/journal.pone.0247275 PMC 바로가기 [Article Type] Research Article

Neutrophil Extracellular Traps in SARS-CoV2 Related Pneumonia in ICU Patients: The NETCOV2 Study

Medicine

Published on 2021-02-232022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] acute respiratory syndrome Analysis association Blood Blood level Coagulation Concentration coronavirus COVID-19 patients COVID19 decrease defined described died disease Extracellular extracellular trap flow cytometry Hypoxemia ICU ICU admission Infectious disease Inflammatory inflammatory status intensive care lack male median Mortality multivariable NET NETs neutrophils extracellular traps neutrophils extracellular traps PaO pathway Patient patients who survived Pneumonia Primary outcome quantification quantified remained Respiratory failure SARS-CoV-2 SARS-CoV2 severe hypoxemia significantly therapeutic target Whole blood whole blood sample
[DOI] 10.3389/fmed.2021.615984 PMC 바로가기 [Article Type] Medicine

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

인터루킨-6은 치명적인 중증 급성 호흡기 증후군 코로나바이러스 2 폐렴의 발병을 위한 바이오마커입니다

Clinical Trial

Published on 2021-02-182022-08-13
Journal: Frontiers in Immunology [Category] MERS, 바이오마커, 임상,

[키워드] “cytokine storm” acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Alpha arterial blood Binary logistic regression Biomarker Blood C-reactive protein Cohort coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 CRP Cytokine storm death development Disease progression disease severity disease stages fatal pneumonia Hospital de Braga Hyper-inflammatory responses IIb and III IL-1 IL-6 IL-6 level IL-6 levels IL-8 indicated Inflammatory marker inflammatory markers Inflammatory mediators interleukin interleukin-1 Logistic regression Necrosis non-survivor outcome oxygen PaO partial pressure Partial pressure of oxygen Patient peripheral oxygen saturation positive correlation Predictive Predictive value Prognosis prognostic respiratory Respiratory failure response SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus significant negative correlation significantly Stage stages the disease Therapeutics TNFα Tumor tumor necrosis tumor necrosis factor tumor necrosis factor alpha
[DOI] 10.3389/fimmu.2021.613422 PMC 바로가기 [Article Type] Clinical Trial

Long-Lasting Cognitive Abnormalities after COVID-19

Article

Published on 2021-02-132022-10-28
Journal: Brain Sciences [Category] COVID-19,

Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study

Observational Study

Published on 2021-02-082022-10-04
Journal: Critical Care [Category] MERS, 임상,

Efficacy and tolerability of bevacizumab in patients with severe Covid-19

중증 코로나19 환자에서 베바시주맙의 효능 및 내약성

Clinical Trial

Published on 2021-02-052022-08-13
Journal: Nature Communications [Category] MERS, 임상, 진단, 치료법, 치료제,

[키워드] ambient anti-vascular Anti-vascular endothelial growth factor bevacizumab bevacizumab plus standard care body temperature changes Chest computed tomography chest imaging China Clinical efficacy clinical trial comparable Computed tomography conducted control group Controlled trial controls COVID-19 patient COVID-19 patients discharged Drug development endothelial Fever fraction growth factor IMPROVE improving oxygenation inspiration Italy lesion areas/ratio mmHg NCT04275414 oxygen oxygen pressure oxygen saturation oxygen-support status Oxygenation PaO partial arterial oxygen pressure Patient patients Pneumonia pulmonary pathological Randomized controlled trial recruited reduction relative respiratory rate SARS-CoV-2 severe COVID-19 shortening oxygen-support duration shown Significant single-arm single-arm trial standard care Tolerability Treatment Vascular vascular changes VEGF viral infection X-ray
[DOI] 10.1038/s41467-021-21085-8 PMC 바로가기 [Article Type] Clinical Trial

Oxygen metabolism markers as predictors of mortality in severe COVID-19

심각한 COVID-19에서 사망의 예측인자로서의 산소 대사 마커

Observational Study

Published on 2021-02-012022-09-11
Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 바이오마커, 임상,

[키워드] addition All participants Analysis ARDS arterial blood AUC Blood characteristic coronavirus disease Coronavirus disease 2019 COVID-19 Critically ill Critically ill patient critically ill patients cut-off cut-off point Deceased determinant Determinants of mortality had no healthy index individual marker medical record medical records metabolism Mortality oxygen Oxygen consumption Oxygen metabolism oxygen saturation oxygen) PaO partial pressure Participants Patient patients with COVID-19 predictor random number generator receiver operating characteristic respiratory Respiratory failure respiratory index Retrospective analysis selected severe coronavirus disease severe COVID-19 Significant significant differences survivor Survivors the strongest venous venous blood was determined with COVID-19
[DOI] 10.1016/j.ijid.2020.12.012 PMC 바로가기 [Article Type] Observational Study